Appropriate duration of antidepressant medications for prevention of depressive relapse and the impact of life stage

Mol Psychiatry. 2023 Dec;28(12):4937-4938. doi: 10.1038/s41380-023-02023-0. Epub 2023 Mar 7.

Authors

Masaki Kato¹, Hikaru Hori², Aran Tajika³

Affiliations

¹ Department of Neuropsychiatry, Kansai Medical University, Osaka, Japan. katom@takii.kmu.ac.jp.
² Department of Psychiatry, Faculty of Medicine, Fukuoka University, Fukuoka, Japan.
³ Department of Health Promotion and Human Behavior, Kyoto University Graduate School of Medicine/School of Public Health, Kyoto, Japan.

PMID: 36882502
DOI: 10.1038/s41380-023-02023-0

No abstract available

Publication types

Letter

MeSH terms

Antidepressive Agents* / therapeutic use
Depression / drug therapy
Female
Humans
Male
Secondary Prevention* / methods
Time Factors

Substances

Antidepressive Agents